Group One Trading, L.P. Allogene Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 444 shares of ALLO stock, worth $1,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

444

Previous 58,924 99.25%

Holding current value

$1,278

Previous $263,000 99.62%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.23 - $4.38 $130,410 - $256,142	-58,480 Reduced 99.25%	444 $1,000
Q1 2024 May 10, 2024	BUY	$2.92 - $5.63 $62,385 - $120,284	21,365 Added 56.88%	58,924 $263,000
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $40,128 - $61,600	-17,600 Reduced 31.91%	37,559 $120,000
Q3 2023 Nov 09, 2023	BUY	$3.17 - $5.96 $152,645 - $286,991	48,153 Added 687.31%	55,159 $174,000
Q2 2023 Aug 09, 2023	SELL	$4.53 - $6.74 $16,335 - $24,304	-3,606 Reduced 33.98%	7,006 $34,000
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $50,794 - $84,760	10,324 Added 3584.72%	10,612 $52,000
Q4 2022 Feb 09, 2023	BUY	$5.62 - $11.11 $1,618 - $3,199	288 New	288 $1,000
Q1 2022 May 12, 2022	SELL	$7.65 - $15.29 $95,319 - $190,513	-12,460 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$13.13 - $24.52 $122,686 - $229,114	9,344 Added 299.87%	12,460 $186,000
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $30,128 - $39,635	-1,434 Reduced 31.52%	3,116 $80,000
Q2 2021 Aug 10, 2021	SELL	$23.49 - $35.8 $356,883 - $543,909	-15,193 Reduced 76.95%	4,550 $119,000
Q1 2021 May 12, 2021	BUY	$25.79 - $39.02 $485,625 - $734,746	18,830 Added 2062.43%	19,743 $697,000
Q4 2020 Feb 10, 2021	BUY	$25.24 - $43.45 $23,044 - $39,669	913 New	913 $23,000
Q1 2020 May 13, 2020	SELL	$18.22 - $28.25 $109,411 - $169,641	-6,005 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$24.82 - $31.4 $131,546 - $166,420	5,300 Added 751.77%	6,005 $156,000
Q3 2019 Nov 12, 2019	SELL	$26.11 - $32.99 $913 - $1,154	-35 Reduced 4.73%	705 $19,000
Q2 2019 Aug 09, 2019	BUY	$25.56 - $31.09 $12,780 - $15,545	500 Added 208.33%	740 $20,000
Q1 2019 May 13, 2019	BUY	$24.82 - $32.54 $5,956 - $7,809	240 New	240 $7,000

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

132M

Call Options Held

94.3K

Put Options Held

112K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $414M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Allogene Therapeutics, Inc. Transaction History